This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jun;8(6):300.

doi: 10.1038/nrgastro.2011.65.

Cancer: CD40 agonists--a promising new treatment for pancreatic cancer?

PMID: 21643028
DOI: 10.1038/nrgastro.2011.65

Comment

Cancer: CD40 agonists--a promising new treatment for pancreatic cancer?

Shreeya Nanda. Nat Rev Gastroenterol Hepatol. 2011 Jun.

. 2011 Jun;8(6):300.

doi: 10.1038/nrgastro.2011.65.

Author

PMID: 21643028
DOI: 10.1038/nrgastro.2011.65

No abstract available

PubMed Disclaimer

Comment on

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, Torigian DA, O'Dwyer PJ, Vonderheide RH. Beatty GL, et al. Science. 2011 Mar 25;331(6024):1612-6. doi: 10.1126/science.1198443. Science. 2011. PMID: 21436454 Free PMC article. Clinical Trial.

References

1. Science. 2011 Mar 25;331(6024):1612-6 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Research Materials
- NCI CPTC Antibody Characterization Program